gkt137831
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT02010242)
Timeline
Indications
Mechanism of action
- NADPH oxidase 4INHIBITOR
NOX4 inhibitor
- NADPH oxidase 1INHIBITOR
NOX1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gkt137831
- gkt137831
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03865927 | Phase 2 | Aug 1, 2019 | University of Alabama, Birmingham |
| NCT03740217 | Phase 1 | Dec 19, 2018 | Eurofins, Genkyotex Innovation SAS, York Bioanalytical Solutions |
| NCT03226067 | Phase 2 | Jun 26, 2017 | Genkyotex Innovation SAS |
| NCT02010242 | Phase 2 | Oct 1, 2013 | Genkyotex Innovation SAS |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genkyotex Innovation SAS | For profit | 3 | 3 | 2 | 2013 |
| Eurofins | For profit | 1 | 0 | 1 | 2018 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2019 |
| York Bioanalytical Solutions | For profit | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1